Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
CRYPTO
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
TECHNOLOGY
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
JIM CRAMER
Cramer's Mad Money Recap: Coca-Cola, United Airlines
By Scott Rutt
Apr 16, 2021 8:39 PM EDT
INVESTING
Latest Upgrades and Downgrades: Bristol-Myers Squibb, Splunk, Tesla
By Rob Lenihan
Apr 16, 2021 3:48 PM EDT
INVESTING
Bristol Myers Gastric-Cancer Treatment Cleared by FDA
By Dan Weil
Apr 16, 2021 2:40 PM EDT
INVESTING
Stock Market Today With Jim Cramer: Buy These Stocks Over Pfizer
By Vidhi Choudhary
Apr 16, 2021 3:35 PM EDT
Video
Jim Cramer's Advice for Spotting a Healthcare Winner
Apr 16, 2021 1:57 PM EDT
INVESTING
Bristol-Myers Upgraded to Buy at Truist on Pipeline Strength
By Dan Weil
Apr 13, 2021 9:00 AM EDT
PRESS RELEASES
Huyabio International Announces Global Clinical Trial Collaboration With Bristol Myers Squibb In Melanoma
By PR Newswire
Mar 30, 2021 8:05 AM EDT
PRESS RELEASES
Bristol Myers Squibb To Host Virtual Investor Event To Discuss AAD VMX Highlights
By Business Wire
Mar 30, 2021 6:59 AM EDT
STOCKS
5 Top Stock Gainers Monday: Fly Leasing, Houghton Mifflin, Boeing
By Rob Lenihan
Mar 29, 2021 4:23 PM EDT
INVESTING
Premarket Movers Monday - ViacomCBS, Bluebird Bio, Discovery
By Vidhi Choudhary
Mar 29, 2021 8:49 AM EDT
INVESTING
Bluebird Bio Rises as FDA Approves Myeloma Treatment
By Rob Lenihan
Mar 29, 2021 8:38 AM EDT
PRESS RELEASES
European Medicines Agency Validates Bristol Myers Squibb's Application For Opdivo (nivolumab) As Adjuvant Treatment For Patients With Muscle-Invasive Urothelial Carcinoma
By Business Wire
Mar 29, 2021 6:59 AM EDT
PRESS RELEASES
(Photo: Business Wire)
By Business Wire
Mar 26, 2021 10:59 PM EDT
PRESS RELEASES
U.S. Food And Drug Administration (FDA) Accepts Bristol Myers Squibb's Application For Mavacamten In Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)
By Business Wire
Mar 19, 2021 6:59 AM EDT
JIM CRAMER
Lightning Round Stocks to Buy From 'Mad Money' With Jim Cramer
By Danny Peterson
Mar 15, 2021 10:23 AM EDT
PRESS RELEASES
Bristol Myers Squibb To Report Results For First Quarter 2021 On April 29, 2021
By Business Wire
Mar 11, 2021 6:59 AM EST
Video
Jim Cramer Wants Healthier Gains From Healthcare Stocks
Mar 8, 2021 9:15 AM EST
PRESS RELEASES
Bristol Myers Squibb To Participate In Barclays Virtual Global Healthcare Conference
By Business Wire
Mar 2, 2021 6:59 AM EST
PRESS RELEASES
Bristol Myers Squibb Announces Dividend
By Business Wire
Mar 1, 2021 4:16 PM EST
PRESS RELEASES
The New England Journal Of Medicine Publishes Results From Pivotal Phase 2 KarMMa Study Of Idecabtagene Vicleucel (Ide-cel, Bb2121), An Investigational BCMA-Directed CAR T Cell Therapy
By Business Wire
Feb 24, 2021 5:30 PM EST
PRESS RELEASES
Bristol Myers Squibb To Take Part In The Cowen Virtual 41st Annual Health Care Conference
By Business Wire
Feb 24, 2021 7:10 AM EST
PRESS RELEASES
MS In Harmony
By Business Wire
Feb 23, 2021 9:00 AM EST
PRESS RELEASES
Bristol Myers Squibb To Participate In Raymond James Virtual 42nd Annual Institutional Investors Conference
By Business Wire
Feb 23, 2021 6:59 AM EST
PRESS RELEASES
Bristol Myers Squibb And Celgene Issue Notices Of Redemption And Partial Redemption Of Certain Of Their Senior Notes At "Make Whole" Prices
By Business Wire
Feb 22, 2021 6:15 PM EST
INVESTING
Heat Biologics Jumps on Progress With Lung-Cancer Drug
By Tony Owusu
Feb 9, 2021 10:08 AM EST
